XML 43 R36.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Financial Instruments (Aquisition of CyDex) (Details) (Cydex Pharmaceuticals, Inc, USD $) In Millions, unless otherwise specified | 6 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 30, 2014 | Dec. 31, 2013
Credit Derivatives [Line Items] |  |  |  |
Amount Of Revenue For Contingent Consideration | $ 15 |  |  |
Contingent Consideration Classified as Equity |  |  |  |
Credit Derivatives [Line Items] |  |  |  |
Revenue volatility | 25.00% |  | 25.00% |
Average of probability of commercialization | 79.30% |  | 67.60% |
Sales beta | 0.60 |  | 0.60 |
Credit rating | BBB |  | BBB |
Equity risk premium | 6.00% |  | 6.00% |
Minimum | Contingent Consideration Classified as Equity |  |  |  |
Credit Derivatives [Line Items] |  |  |  |
Range of annual revenue subject to revenue sharing | 13.1 | [1] | 4.2 | [1]
Maximum | Contingent Consideration Classified as Equity |  |  |  |
Credit Derivatives [Line Items] |  |  |  |
Range of annual revenue subject to revenue sharing | $ 18.9 | [1] | $ 19.8 | [1]
[1] | Revenue subject to revenue sharing represent management’s estimate of the range of total annual revenue subject to revenue sharing (i.e. annual revenues in excess of $15 million) through December 31, 2016, which is the term of the CVR agreement.

X
- Definition Amount of revenue for contingent consideration. + References No definition available. + Details
Name: | lgnd_AmountOfRevenueForContingentConsideration
Namespace Prefix: | lgnd_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Fair Value Inputs, Annual Revenue Subject To Revenue Sharing + References No definition available. + Details
Name: | lgnd_FairValueInputsAnnualRevenueSubjectToRevenueSharing
Namespace Prefix: | lgnd_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Average Probability of Commercialization + References No definition available. + Details
Name: | lgnd_FairValueInputsAverageOfProbabilityOfCommercialization
Namespace Prefix: | lgnd_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair Value Inputs, Credit Rating + References No definition available. + Details
Name: | lgnd_FairValueInputsCreditRating
Namespace Prefix: | lgnd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair Value Inputs, Sales Beta + References No definition available. + Details
Name: | lgnd_FairValueInputsSalesBeta
Namespace Prefix: | lgnd_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_CreditDerivativesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssumptionsExpectedVolatilityRate
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage above fair value that an investor seeking to acquire control of an entity will pay, used as an input to measure fair value. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueInputsControlPremium
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration